Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 22,170 shares at $36.67 ($813K) on 2025-08-08, disclosed to the SEC on 2025-08-12.
Scheduled sale ($813k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.67 | 11,085 | $406K | 50.0% |
| 2 | $36.67 | 11,085 | $406K | 50.0% |
| Total | $36.67 avg | 22,170 | $813K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $507K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |
| AGIO | SELL | 2025-03-04 | $920K | — | Filing → |